Your browser doesn't support javascript.
loading
Tuberculosis patients in primary care do not start treatment. What role do health system delays play?
Claassens, M M; du Toit, E; Dunbar, R; Lombard, C; Enarson, D A; Beyers, N; Borgdorff, M W.
Afiliación
  • Claassens MM; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa. mcla@sun.ac.za
Int J Tuberc Lung Dis ; 17(5): 603-7, 2013 May.
Article en En | MEDLINE | ID: mdl-23575324
ABSTRACT

SETTING:

Primary health care facilities in five provinces of South Africa.

OBJECTIVE:

To investigate the association between the proportion of sputum results with a prolonged smear turnaround time and the proportion of smear-positive tuberculosis (TB) cases initially lost to follow-up.

DESIGN:

The unit of investigation was a primary health care facility and the outcome was the initial loss to follow-up rate per facility, which was calculated by comparing the sputum register with the TB treatment register. A prolonged turnaround time was defined as more than 48 h from when the sputum sample was documented in the sputum register to receipt of the result at the facility.

RESULTS:

The mean initial loss to follow-up rate was 25% (95%CI 22-28). Smear turnaround time overall was inversely associated with initial loss to follow-up (P = 0.008), when comparing Category 2 (33-66% turnaround time within 48 h) with Category 1 (0-32%) (OR 0.73, 95%CI 0.48-1.13, P = 0.163) and when comparing Category 3 (67-100%) with Category 1 (OR 0.62, 95%CI 0.39-0.99, P = 0.045). The population preventable fraction of initial loss to follow-up (when turnaround time was <48 h in ≥67% of smear results) was 21%.

CONCLUSION:

Initial loss to follow-up should be reported as part of the TB programme to ensure that patients are initiated on treatment to prevent transmission within communities.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Atención Primaria de Salud / Tuberculosis Pulmonar / Tiempo de Tratamiento / Antituberculosos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Equity_inequality Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Int J Tuberc Lung Dis Año: 2013 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Atención Primaria de Salud / Tuberculosis Pulmonar / Tiempo de Tratamiento / Antituberculosos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Equity_inequality Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Int J Tuberc Lung Dis Año: 2013 Tipo del documento: Article País de afiliación: Sudáfrica